TIDMAGI

RNS Number : 7506D

AGI Therapeutics plc

28 March 2011

AGI Therapeutics plc

('AGI' or the 'Company')

Directors' Dealing

AGI was informed on 25 March 2011 that David Kelly, a Director and Chief Financial Officer of AGI, purchased 550,000 ordinary shares of EUR0.01 each ("Ordinary Share") in the share capital of the Company at a price of EUR0.045 per Ordinary Share on 25 March 2011.

Following this purchase, David Kelly's beneficial shareholding in the Company is 655,000 Ordinary Shares.

Contact Information:

David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSPGUMPWUPGGWR

Grafico Azioni AGI (LSE:AGI)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di AGI
Grafico Azioni AGI (LSE:AGI)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di AGI